The bill expresses the House of Representatives' sense that mifepristone, a medication for abortion, is safe and effective, and that access to it.
The bill emphasizes the importance of respecting over 25 years of evidence and hundreds of peer-reviewed studies that demonstrate mifepristone's safety and effectiveness. It calls for equitable, transparent, and science-based policies governing access to medication abortion care. The bill highlights the disproportionate impact of abortion restrictions on marginalized communities, including Black and Indigenous people, people of color, immigrants, those with lower incomes, people in rural areas, LGBTQ+ individuals, people with disabilities, and those experiencing intimate partner violence.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.